New Delhi, June 6 -- India's listed hospitals are likely to maintain double-digit revenue growth even as EBITDA margins stay rangebound due to a hectic bed-addition cycle, brokerage firm Kotak Securities said in a research report.

With ARPOB growth of 6-14 per cent YoY for most players, strong Inpatient Department volumes and diagnostics B2C traction picking up, the brokerage sees top-line momentum holding.

The March quarter was overall a "fine quarter", said Kotak. Hospitals delivered 18 per cent YoY sales growth and 16 per cent YoY EBITDA growth. ARPOB growth was healthy at 6-14 per cent YoY for most hospitals, led by a reduction in ALOS and a better speciality mix. KIMS posted 14 per cent YoY ARPOB growth on contributions from high-A...